What is Jasper Therapeutics Inc?
, a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. Its products in various stages of development include KP-104, a dual-complement inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) which is in Phase 2; Briquilimab is an anti-KIT antibody, which has demonstrated clinical results as a conditioning agent for stem cell transplant and mast cell mediated diseases, such as chronic urticarias and allergic asthma; and KP-701, a novel, dual-acting anti-CD79BxCD32B monoclonal antibody (mAb) for autoantibody-mediated disorders. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 9.64M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.